---
figid: PMC6834141__ijms-20-05034-g002
figtitle: Simplified overview of the signaling pathways in the target cells presented
  in this review that are relevant for the development of a pharmacological therapy
  rationale
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Canis lupus familiaris
- Sus scrofa
- Ovis aries
- Mus musculus
- Rattus norvegicus
- Caenorhabditis elegans
- Drosophila sp. in flies
- Homo sapiens
- Human immunodeficiency virus 1
- Olea europaea
- NA
pmcid: PMC6834141
filename: ijms-20-05034-g002.jpg
figlink: /pmc/articles/PMC6834141/figure/ijms-20-05034-f002/
number: F2
caption: Simplified overview of the signaling pathways in the target cells presented
  in this review that are relevant for the development of a pharmacological therapy
  rationale. Systemic modulators were excluded from the figure. The RISK pathway (in
  green) is commonly activated via G-protein coupled receptors by opioids, bradykinin,
  and adenosine or the receptor tyrosine kinase, by erythropoietin, cytokines, insulin
  or insulin-like growth factor-1. The cGMP/PKG pathway (in green) receives external
  stimuli through the activation of the natriuretic peptide receptor, by natriuretic
  peptides A and B (ANP, BNP). The SAFE pathway is engaged via the glycoprotein 130
  receptor or TNF-α receptor type 2 by IL-6, IL-11, leukemia inhibitory factor (LIF)
  or TNF-a. A fourth pathway, the TNF- α receptor type-1 is the only of deleterious
  character depicted in this figure. The xanthine-oxidase (XO) and sarco/endoplasmic
  reticulum Ca2+-ATPase (SERCA) pathways are shown only in order to highlight their
  targets. Pointed arrows mean stimulation, blunt arrows mean inhibition.
papertitle: 'Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological
  Strategies.'
reftext: Ricardo O. S. Soares, et al. Int J Mol Sci. 2019 Oct;20(20):5034.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9631295
figid_alias: PMC6834141__F2
figtype: Figure
organisms_ner:
- Ovis aries
- Bos taurus
- Rattus norvegicus
- Canis lupus familiaris
- Sus scrofa
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC6834141__F2
ndex: b567cb28-ded5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6834141__ijms-20-05034-g002.html
  '@type': Dataset
  description: Simplified overview of the signaling pathways in the target cells presented
    in this review that are relevant for the development of a pharmacological therapy
    rationale. Systemic modulators were excluded from the figure. The RISK pathway
    (in green) is commonly activated via G-protein coupled receptors by opioids, bradykinin,
    and adenosine or the receptor tyrosine kinase, by erythropoietin, cytokines, insulin
    or insulin-like growth factor-1. The cGMP/PKG pathway (in green) receives external
    stimuli through the activation of the natriuretic peptide receptor, by natriuretic
    peptides A and B (ANP, BNP). The SAFE pathway is engaged via the glycoprotein
    130 receptor or TNF-α receptor type 2 by IL-6, IL-11, leukemia inhibitory factor
    (LIF) or TNF-a. A fourth pathway, the TNF- α receptor type-1 is the only of deleterious
    character depicted in this figure. The xanthine-oxidase (XO) and sarco/endoplasmic
    reticulum Ca2+-ATPase (SERCA) pathways are shown only in order to highlight their
    targets. Pointed arrows mean stimulation, blunt arrows mean inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - IL11
  - LIF
  - IGF1
  - NPPA
  - NPPB
  - TNF
  - RECEPTOR
  - FADD
  - AKT1
  - STAT3
  - NOS3
  - PRKACA
  - NOS2
  - CCND1
  - VEGFA
  - BCL2
  - BCL2L1
  - COX2
  - MCL1
  - SOD2
  - HMOX1
  - Il6
  - Il11
  - Lif
  - Igf1
  - Nppa
  - Nppb
  - Tnf
  - Psors1c2
  - Fadd
  - Ephb1
  - Akt1
  - Stat3
  - Nos3
  - Nos2
  - Ccnd1
  - Sod2
  - Vegfa
  - Bcl2
  - Bcl2l1
  - Ptgs2
  - Mcl1
  - Hmox1
  - PTGS2
  - IL-6
  - RPS6KB1
  - NOS1
  - CCND2
  - BCL-2
  - PRKG1
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT2
  - AKT3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - RPS6KB2
  - ENO4
  - NT5C2
  - ATP2A1
  - ATP2A2
  - ATP2A3
  - ISYNA1
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - Lifr
  - Mdk
  - pk
  - Ephb2
  - Mapk1
  - Rps6kb1
  - Nt5c2
  - bradykinin
  - adenosine
  - tyrosine
  - 'NO'
  - MPTP
---
